![](https://cdn.sanity.io/images/0vv8moc6/psychtimes/d1edbea75506de4e9c94da366bda2dadd4af6507-4679x3206.jpg?fit=crop&auto=format)
What Matters Most in Psychedelic-Assisted Psychotherapy?
CLINICAL REFLECTIONS In June, an advisory committee for the US Food and Drug Administration (FDA) recommended rejecting the psychedelic drug, midomafetamine (MDMA), as a potential treatment for posttraumatic stress disorder (PTSD). After reviewing the …